# Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus

> **NCT01475552** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 130 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Abciximab
- **DRUG:** control

## Key facts

- **NCT ID:** NCT01475552
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-10
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2012-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475552, "Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01475552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*